Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

Many months ago I speculated about whether this is why the PPS was quietly being allowed to remain down despite so many indications of VERY positive business developments. Other related questions: (1) does splitting CaverStem off make it any more/less likely that they would entertain buyout? (2) what exactly will be the impact of the split-off on current shareholder equity? (3) does CaverStem international INCLUDE current US interests (would seem to make more sense—why would they bifurcate yet again by having TWO CaverStem entities?)? In the end, I cannot see them selling everything (why would they with so much in development that we have no way to estimate the value of?). If ANYTHING is sold, it would probably be CaverStem (which has been split off already) and then using that money to promote and commercialize all the other product lines, beginning with Femcelz and Amniostem. LASTLY, given the indications that CaverStem results in growth of NEW vessels and the implications of this for increasing size, they’d better not settle for ANYTHING other than a MASSIVE payday for CaverStem alone!